Revamped Cancer Drugs Fund Means More Positive Recommendations, Says NICE
Executive Summary
NICE, the health technology appraisal body for England and Wales, has rejected criticism that access to cancer drugs is worsening in the UK. The institute pointed to the revamped Cancer Drugs Fund which it said meant more positive recommendations.